As global agriculture searches for more sustainable ways to improve crop production, investors are increasingly paying attention to biological technologies that can enhance soil health, boost plant performance, and reduce reliance on traditional chemical inputs. One emerging agricultural innovator is expanding the commercial reach of its mustard-derived products, advancing an international relationship with Bayer (USOTC:BAYRY), and positioning itself to capitalize on growing demand for biologica

MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF, FRA:0C0) has reported a sharp increase in revenue for 2025 as it expanded its biological and regenerative agriculture offering. For the year ended December 31, 2025, the company generated sales revenue of $8.3 million, up from $0.4 million in...

MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF, FRA:0C0) said Tuesday it has received registration approval from the Georgia Department of Agriculture for its mustard plant-based TerraSante organic biofertility product, expanding the company's commercial footprint in the southeastern...

Oil prices have surged as the Federal Reserve begins its two-day policy meeting

MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF, FRA:0C0) said on Tuesday it will close its wholly owned Canadian marketing and distribution arm NexusBioAg in April, as the company pivots capital toward its proprietary TerraSante biofertility product in the United States. NexusBioAg, which...